Granite Harbor Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Sell
2,123
-9
-0.4% -$9.2K 1.01% 24
2026
Q1
$1.96M Buy
2,132
+9
+0.4% +$9.12K 0.86% 28
2025
Q4
$2.28M Sell
2,123
-26
-1% -$24.9K 0.96% 26
2025
Q3
$1.64M Buy
2,149
+4
+0.2% +$2.98K 0.69% 33
2025
Q2
$1.67M Buy
2,145
+61
+3% +$47.4K 0.79% 28
2025
Q1
$1.72M Buy
2,084
+843
+68% +$701K 0.91% 26
2024
Q4
$958K Buy
1,241
+5
+0.4% +$4.14K 0.53% 38
2024
Q3
$1.1M Buy
1,236
+662
+115% +$595K 0.63% 34
2024
Q2
$520K Sell
574
-4
-0.7% -$3.2K 0.33% 56
2024
Q1
$450K Sell
578
-7
-1% -$4.98K 0.31% 56
2023
Q4
$341K Buy
585
+40
+7% +$23.3K 0.26% 55
2023
Q3
$293K Hold
545
0.24% 64
2023
Q2
$256K Buy
+545
New +$229K 0.2% 69

Other funds holding LLY

Granite Harbor Advisors's LLY Position: Q2 2026 in Review

Granite Harbor Advisors reduced its Eli Lilly (LLY) stake by 0.42% in Q2 2026, selling an estimated $9.2K and leaving 2,123 shares worth $2.55M. The position accounts for 1.01% of the portfolio, ranked #24.

Granite Harbor Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Granite Harbor Advisors held 2,123 shares of Eli Lilly worth $2.55M as of Q2 2026.
  • Granite Harbor Advisors sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 1.01% of Granite Harbor Advisors's portfolio in Q2 2026, its #24 holding.
  • Granite Harbor Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.